Fed Sinks Markets
Health Care: Health Services
EnteroMedics Inc. (ETRM: NASDAQ)
$1.22 0.04 | 3.39%
06/19/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 311.49K | 0.00 | 0.00 | 0.00 |
| Cost of Sales | 231.52K | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 79.97K | 0.00 | 0.00 | 0.00 |
| Selling, General, and Administrative Expenses | 11.96M | 8.58M | 7.68M | 8.63M |
| Research & Development | 10.67M | 16.67M | 8.50M | 15.58M |
| Operating Income before D & A (EBITDA) | -22.55M | -25.26M | -16.18M | -24.21M |
| Depreciation & Amortization | 439.02K | 541.97K | 763.62K | 1.92M |
| Interest Income | 9.88K | 12.24K | 5.60K | 79.36K |
| Other Income - Net | -19.18K | -30.12K | 82.54K | -3.69M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -23.00M | -25.82M | -16.85M | -29.74M |
| Interest Expense | 901.84K | 722.86K | 1.26M | 4.10M |
| Pre-Tax Income | -23.90M | -26.54M | -18.11M | -33.85M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -23.46M | -26.00M | -17.35M | -31.93M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -23.46M | -26.00M | -17.35M | -31.93M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -23.46M | -26.00M | -17.35M | -31.93M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-23.46M | -26.00M | -17.35M | -31.93M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -23.46M | -26.00M | -17.35M | -31.93M |
| Basic EPS from Continuing Ops. | -0.59 | -0.86 | -2.06 | -6.42 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.59 | -0.86 | -2.06 | -6.42 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.59 | -0.86 | -2.06 | -6.42 |
| Basic Normalized Net Income/Share | -0.59 | -0.86 | -2.06 | -6.42 |
| EPS fr Continuing Ops. | -0.59 | -0.86 | -2.06 | -6.42 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.59 | -0.86 | -2.06 | -6.42 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.59 | -0.86 | -2.06 | -6.42 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.59 | -0.86 | -2.06 | -6.42 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ETRM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- UserPART 7 JPMorgan 28th Annual...
- ContributorBarron's Insider Purchases ...
- UserPART 5 JPMorgan 27th Annual...
- UserPART 3 JPMorgan 26th Annual...
- UserBarron's Insider Purchases ...
Latest ETRM Headlines from TheStreet
- The Five Dumbest Things on Wall Street This Week: Feb. 15 02.15.13 | 07:02 am
- EnteroMedics Weight-Loss Device Is A Pulsing Placebo 02.07.13 | 05:02 pm
- EnteroMedics: Fat Zapper or Pulsing Placebo? 02.06.13 | 08:02 am
- 5 Stocks Under $10 Set to Soar 06.28.12 | 11:06 am
- 5 Stocks Insiders Think Are Worth It 09.28.11 | 02:09 pm
- Playboy, TIB Financial: Volume Movers 06.30.10 | 08:06 am
- Navarro's High Volume Movers
06.23.10 | 09:06 am - EnteroMedics, Bionovo: Early Volume Plays 01.14.10 | 09:01 am
- EnteroMedics: Pump Up The Volume 10.02.09 | 11:10 am
- Winners and Losers: Nova Chemicals 02.23.09 | 04:02 pm
Press Releases for ETRM
- EnteroMedics Announces Closing Of $29.8 Million Public Offering Of Common Stock And Warrants - Business Wire 12.14.10 | 02:12 pm
- EnteroMedics Announces Regulatory Path Forward Following FDA Meeting - Business Wire 01.28.10 | 07:01 am
Partner Headlines for ETRM
- A Look At 3 Obesity Stocks - Seeking Alpha 03.05.13 | 09:03 am
- 3 Rallying Stocks Under $5 Being Bought Up By Company Insiders - Seeking Alpha 07.22.12 | 09:07 am
- Rochester Medical's OUTPERFORM Boost and 4 Stock Analysts Initiating Coverage - Wall St. Cheat Sheet 06.29.12 | 04:06 am
- BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011 - Seeking Alpha 12.28.10 | 03:12 am
- UPDATE 1-EnteroMedics says obesity device data positive, shrs up - Reuters 10.20.10 | 11:10 am
- UPDATE 3-EnteroMedics shares soar on promise of obesity device - Reuters 06.22.10 | 05:06 pm
- Competitive Technologies: A Game Changer in Pain Management? - Seeking Alpha 05.14.10 | 05:05 pm
